This article discusses the necessity of storing and exchanging wagon movement data using specific messages, highlighting challenges with the current implementation and proposing modifications to the TAF system. The formation of a Telematics Expert Group (TEG) for wagon movement maintenance is outlin

0 views • 5 slides

Explore the latest research presented by Gilead at CROI 2023 in Seattle, featuring abstracts on HIV treatment response predictors, long-acting Lenacapavir, F/TAF outcomes, HIV prevention, and exciting progress in HIV cure research. Don't miss the insightful findings and promising developments in the

0 views • 16 slides

Early Years Co-construction Project in Cwm Taf aims to reconfigure services, create a local Early Years system for 0-7 years, and improve coordination and integration. The phased approach includes defining, fact-finding, implementing evidence-based interventions, and final design. System-wide priori

0 views • 7 slides

The BRAAVE 2020 study focused on Black American adults with HIV who were virologically suppressed and switched to B/F/TAF treatment. The study analyzed outcomes at Weeks 0, 24, 48, and 72, with an extension phase involving 330 participants. Operational challenges due to COVID-19 were addressed throu

0 views • 8 slides

Study results reveal that F/TAF provides rapid onset and longer sustained HIV protection compared to F/TDF in pre-exposure prophylaxis. The randomized noninferiority trial included 2694 participants with a primary analysis at weeks 48 and 96. Disclosure statements indicate involvement of various hea

0 views • 21 slides

The abstracts selected by Gilead Medical Affairs Germany for AIDS 2020 cover a range of topics related to HIV treatment and research. Topics include safety and efficacy of B/F/TAF in older adults, real-world effectiveness of B/F/TAF in clinical practice, prevalence of resistance in PLWH, and the lat

0 views • 13 slides